The ARKG fund operates as an actively managed Exchange Traded Fund (ETF), aiming to achieve significant capital appreciation over an extended period. Its investment strategy involves committing a minimum of 80% of its total assets, under typical market conditions, to equity securities issued by both domestic and international companies. These companies are strategically chosen from various sectors based on their direct connection to the fund's core investment principle: the groundbreaking genomics revolution.

ประเภทสินทรัพย์

Equity

ผู้ออกกองทุน

ARK

ประเทศที่จดทะเบียน

US

วันที่จัดตั้ง

31 ต.ค. 2557

จำนวนหลักทรัพย์

10

ISIN

US00214Q3020